Scientific Program

The conference will include 3 tracks:

  • Plenary Sessions – 8th, 9th & 10th April
  • Workshop 1 – 9th & 10th April
  • Workshop 2 – 9th & 10th April

Scientific presentations from leaders in the field

Daily Working Group Updates and Discussion Sessions on Precision Medicine for:

  • Type 1 diabetes
  • Gestational diabetes
  • Type 2 Diabetes
  • Monogenic diabetes

Short Oral Presentations (E-posters) with mentored discussions, with focus on early career participants, mentorship and meet-the-professor sessions


Programs

Legend

      - Plenary Sessions
      - Workshops



PDM2021. SCIENTIFIC PROGRAM

Each day of the virtual conference will include a series of plenary talks from key stakeholders and experts in various aspects of precision diabetes medicine, followed by a featured keynote talk from an individual living with diabetes. The Virtual Poster Hall will be open during the entirety of the virtual event to showcase scientific efforts in the field.

8th April 2021 ( Plenary Session )
Time (EDT) Session / Topic Chair / Speaker
8:00-10:00 Vision and Direction of the Precision Medicine for Diabetes Initiative John Nolan, MD & Christine Lee, MD
08:00-08:10 Welcome and opening remarks Tracey Brown, CEO, American Diabetes Association
08:10-08:20 Opening remarks Stefano Del Prato, President, European Association for the Study of Diabetes
08:20-08:40 Keynote: The Precision Medicine in Diabetes Initiative – Treating the Whole Person Robert Gabbay, Chief Scientific and Medical Officer, American Diabetes Association
08:40-09:00 Keynote: Real Life Needs of People with Diabetes Dana Lewis, US, living with type 1 diabetes
09:00-09:20 Precision Medicine and the Research Agenda for Diabetes William Cefalu, Director, Division of Diabetes, Endocrinology and Metabolic Disease, NIDDK
09:20-09:40 The Precision Medicine in Diabetes Initiative – Vision and Future Direction Paul Franks, Co-chair, ADA/EASD Precision Medicine in Diabetes Initiative
09:40-10:00 A Vision for Future Diabetes Care based on Precision Martin Ridderstråle, Senior Vice President and Head of Patient Care, Novo Nordisk Foundation
10:00-11:00 Moderated, Early-Career Poster Presentations Bob Eckel, MD
10:00-10:05 Longitudinal phenotypes of type 1 diabetes in youth based on weight and glycemia and their association with complications Anna Kahkoska
10:05-10:10 Comparison of Four Risk Prediction Models for Diabetes Remission After Roux-en-Y Gastric Bypass Surgery in Obese Chinese Patients with Type 2 Diabetes Mellitus Kam Hoi Man
10:10-10:15 Genome-wide association study reveals genetic overlap between placental weight, birth weight and diabetes. Christopher Flatley
10:15-10:20 Precision medicine in type 2 diabetes: Predictors of differential HbA1c response to SGLT2-inhibitors identified in primary care data are replicated in EMPA-REG OUTCOME trial data Katherine Young
10:20-10:25 In vitro functional analysis of human HNF1B variants aid variant interpretation and clinical diagnostics Aishwarya Pavithram
10:25-10:30 A type 1 diabetes diagnostic model including type 1 diabetes genetic risk score and clinical features aids in classification of adult patients with clinical type 1 diabetes that are islet autoantibody negative Josefine Tecklenborg
10:30-10:35 The interplay between polygenic and rare HNF1A variant risk in type 2 diabetes. Lauren Stalbow
10:35-10:40 Genetics and Clinical Characteristics of PPARG Variants Induced Diabetes in a Chinese Han Population Siqian Gong
10:40-10:45 Prognostic markers of diabetes-associated mortality in clinical notes: a retrospective cohort analysis using machine learning and unstructured big data Kushan De Silva
10:45-11:00 Precision diagnostics in diabetes: Unraveling the disease causality of HNF1B coding variants in two large Norwegian diabetes registries Ingvild Losnegard Koløen
9:00-11:30 Clinical and Scientific Challenges and Opportunities for Precision Diabetes Medicine Ruth Weinstock, MD, PhD & Anna Kahkoska, PhD
09:00-09:15 Keynote: Personalizing Diabetes Care in 2021 John Buse, Chief, Division of Endocrinology, University of North Carolina at Chapel Hill
09:15-09:30 Keynote: Living and staying healthy with type 2 diabetes Adithya Menon, India, living with type 2 diabetes
09:30-09:50 Precision Diabetes in South Asians V Mohan, Chair, Dr Mohan’s Diabetes Specialties Centre, Chennai, India
09:50-10:10 Sub-classification of diabetes: Possibilities and Challenges Miriam Udler, Massachusetts General Hospital and Broad Institute, Boston, US
10:10-10:30 Precision Approach to Diabetes in Pregnancy Marie-France Hivert, Dept of Population Medicine, Harvard Medical School
10:30-10:50 Approach to Precision Medicine for ‘Common’ Type 2 diabetes Chris Rhodes, Chief Scientist, Cardiovascular, Renal and Metabolism, Astra Zeneca, Gaithersburg, MD, US
10:50-11:10 Precision Prevention of Type 1 Diabetes Jessica Dunne, Janssen Pharmaceuticals, New Jersey, US
11:10-11:30 Panel discussion
Time (EDT) Session Topic Chair/ Presenter
8:00-09:00 Precision Type 1 Diabetes Chair: Steve Rich, PhD
08:00-08:15 Type 1 Diabetes Precision Diagnostics Type 1 Diabetes Diagnostics Precision Medicine in Diabetes Workgroup Maria Jose Redondo, MD, PhD, MPH Professor of Pediatrics Diabetes and Endocrinology Texas Children's Hospital Baylor College of Medicine
08:15-08:30 Type 1 diabetes Precision prevention Towards Precision Prevention in Type 1 Diabetes Mike Haller, MD Professor and Chief Pediatric Endocrinology University of Florida
08:30-08:45 Type 1 diabetes Precision treatment Management of Type 1 Diabetes: Efforts towards Precision Treatments Jennifer Sherr, MD, PhD Associate Professor in Pediatrics (Endocrinology) Yale School of Medicine
Lori Laffel, MD, MPH Chief, Pediatric, Adolescent, and Young Adult Section, Joslin Diabetes Centre, Boston
Chantal Mathieu, MD, PhD Medical Head, Department of Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, Leuven
08:45-09:00 Type 1 diabetes Precision prognostics Precision Prognostics in T1D Rodica Busui, MD, PhD Larry D. Soderquist Professor of Internal Medicine Metabolism, Endocrinology and Diabetes Department of Internal Medicine Elizabeth Weiser Caswell Diabetes Institute University of Michigan
Time (EDT) Session Topic Chair/ Presenter
8:00-09:00 Precision Gestational Diabetes Chair: Marie-France Hivert, MD
08:00-08:15 GDM Precision diagnostics Toward a Precision Approach to Gestational Diabetes Diagnosis. Camille Powe Assistant Professor, Harvard Medical School Diabetes Unit, Endocrine Division Massachusetts General Hospital Boston
08:15-08:30 GDM Precision prevention Precision prevention of GDM: identifying evidence gap Kimberly Vesco; MD, MPH Kaiser Permanente Center for Health Research, Portland, OR, USA
08:30-08:45 GDM Precision Prognostic Long-term consequences of exposure to gestational diabetes in utero: USE OF ‘OMICSs Wei Perng Asst Professor University of Colorado Denver - Anschutz Medical Campus
08:45-09:00 GDM Precision treatment What is the potential for precision treatment in gestational diabetes Rebecca Reynolds Professor of Metabolic Medicine Centre for Cardiovascular Science Queen's Medical Research Institute Edinburgh EH16 4TJ
9:00-11:20 From History to Future Policy— Broader Context for Precision Diabetes Medicine Chairs: Cynthia Muñoz, PhD, MPH & Zhila Semnani-Azad, BSc
09:00-09:15 Keynote: Precision Diabetes Care – a historical perspective on race and disease Arleen Tuchman, Nelson O. Tyrone Jr. Professor of History, Vanderbilt University
09:15-09:30 Keynote: The Importance of the Diagnosis Kristin Skiados, living with monogenic diabetes
09:30-09:50 Precision Monitoring and Technology in Diabetes Care David Klonoff, Director, Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, California
09:50-10:10 Precision Monitoring – Approach to Policy Implementation Dirk Mueller-Wieland, Head Clinical Research Centre, Dept of Medicine, University of Aachen, Germany
10:10-10:30 Public-private partnerships in the research approach to Precision Medicine Bernd Stowasser, Sanofi, IMI Strategic Governance Group, Diabetes & Metabolic Disorders
10:30-10:50 The Accelerating Medicines Partnership in Type 2 Diabetes. Philip Smith, Division of Diabetes, Endocrinology & Metabolic Diseases, NIDDK
10:50-11:10 Thoughts on Precision Medicine in Diabetes: an industry perspective Rasmus Rabøl, CVP, Novo Nordisk
11:10-11:20 Panel discussion
11:20-11:30 Closing Remarks Paul Franks, PhD & John Nolan, MD
Time (EDT) Session Topic Chair/ Presenter
8:00-09:00 Precision Type 2 Diabetes Chair: Linong Ji, MD
08:00-08:15 Type 2 Diabetes Precision Diagnostics Precision Diagnostics for Type 2 Diabetes: A vision for improved detection and sub-classification of disease Dr Shivani Misra MRCP, PhD Imperial College London
08:15-08:30 Type 2 diabetes Precision Prevention Do personal, social, or environmental characteristics modify the efficacy of interventions for T2D prevention? Deirdre K Tobias, ScD Associate Epidemiologist, Brigham and Women’s Hospital Assistant Professor, Harvard Medical School and Harvard TH Chan School of Public Health
08:30-08:45 Type 2 Diabetes Precision Prognostics Precision Prognostics in Type 2 Diabetes- Progress and Updates Dr Ronald Ma Dept of Medicine and Therapeutics The Chinese University of Hong Kong Prince of Wales Hospital Hong Kong
08:45-09:00 Type 2 Diabetes Precision Treatment Precision treatment in Type 2 diabetes: Can we predict response and outcomes to diabetes therapies? Ewan Pearson (pre record) Professor of Diabetic Medicine, Head of Division Population Health & Genomics School of Medicine, University of Dundee
John Dennis Independent Research Fellow in Medical Statistics, University of Exeter Medical School, Exeter
Time (EDT) Session Topic Chair/ Presenter
8:00-09:00 Precision Monogenic Diabetes Chair: Lou Philipson, MD, PhD
08:00-08:15 Monogenic Diabetes Precision Diagnostics Precision Diagnostics for Monogenic diabetes: The who’s, how’s and what does it mean?. Anna L Gloyn, DPhil Professor of Pediatrics & by Courtesy of Genetics Associate Chair for Basic Research Department of Pediatrics, Stanford School of Medicine & Stanford Diabetes Research Centre, Stanford University, USA Katharine R Owen MD Associate Professor of Diabetes Oxford Centre for Diabetes Endocrinology & Metabolism, University of Oxford, UK
08:15-08:45 Monogenic Diabetes Precision Prognostics Monogenic Prognostics: How Can a Monogenic Diabetes Diagnosis Help Predict Outcome? Siri Atma W. Greeley, MD, PhD Associate Professor of Pediatrics and Medicine Section of Pediatric and Adult Endocrinology, Diabetes and Metabolism Associate Director for Pediatrics, Kovler Diabetes Center The University of Chicago
08:45-09:00 Monogenic Diabetes Precision Treatment Precision treatment in monogenic diabetes: how diagnosing monogenic diabetes can improve treatment. Professor Andrew Hattersley, DM Professor of Molecular Medicine University of Exeter Medical School UK